3M Resolves PFAS-Related Claims with the State of New Jersey

Core Viewpoint - 3M has reached an agreement to resolve all legacy claims related to the Chambers Works site in New Jersey, including PFAS-related claims from the State of New Jersey, which is subject to court approval [1][5][6] Group 1: Agreement Details - The settlement allows 3M to focus on strategic priorities and reduces risk and uncertainty regarding legacy issues [2][3] - The agreement acknowledges 3M's proactive measures in ceasing PFAS manufacturing, which other companies have not taken [2][4] - The settlement includes a pre-tax present value commitment of approximately $210 million for the Chambers Works litigation and $75 million for future statewide claims starting in 2030 [9][10] Group 2: Financial Implications - 3M expects to record a pre-tax charge of approximately $285 million in Q2 2025, which will be reflected in its financial results [7] - The payment structure of the agreement is designed to provide predictable cash flow over 25 years, aligning with other company obligations [7][9] Group 3: Historical Context - The Chambers Works site has a history of contamination issues, with 3M having supplied PFAS to DuPont at the site until 2001 [4][5] - The agreement resolves not only the legacy claims but also broader statewide PFAS claims, providing finality without further litigation [5][6]